Dr. C. Fein Levy, MD | New Hyde Park ...

Dr. Carolyn F. Levy

Claim this profile

The Steven and Alexandra Cohen Children's Medical Center of New York

Studies Cancer
Studies Rhabdomyosarcoma
7 reported clinical trials
24 drugs studied

Area of expertise

1Cancer
Carolyn F. Levy has run 2 trials for Cancer. Some of their research focus areas include:
Stage I
Stage IV
Stage II
2Rhabdomyosarcoma
Carolyn F. Levy has run 2 trials for Rhabdomyosarcoma. Some of their research focus areas include:
FOXO1 fusion negative
FOXO1 fusion positive
Stage IV

Affiliated Hospitals

Image of trial facility.
The Steven And Alexandra Cohen Children's Medical Center Of New York
Image of trial facility.
Cohen Children's Medical Center

Clinical Trials Carolyn F. Levy is currently running

Image of trial facility.

Chemotherapy

for Cancer

This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
Image of trial facility.

Chemotherapy

for Wilms Tumor

This phase II trial studies how well combination chemotherapy works in treating patients with newly diagnosed stage II-IV diffuse anaplastic Wilms tumors (DAWT) or favorable histology Wilms tumors (FHWT) that have come back (relapsed). Drugs used in chemotherapy regimens such as UH-3 (vincristine, doxorubicin, cyclophosphamide, carboplatin, etoposide, and irinotecan) and ICE/Cyclo/Topo (ifosfamide, carboplatin, etoposide, cyclophosphamide, and topotecan) work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial may help doctors find out what effects, good and/or bad, regimen UH-3 has on patients with newly diagnosed DAWT and standard risk relapsed FHWT (those treated with only 2 drugs for the initial WT) and regimen ICE/Cyclo/Topo has on patients with high and very high risk relapsed FHWT (those treated with 3 or more drugs for the initial WT).
Recruiting1 award Phase 212 criteria

More about Carolyn F. Levy

Clinical Trial Related8 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Carolyn F. Levy has experience with
  • Etoposide
  • Cyclophosphamide
  • Carboplatin
  • Cisplatin
  • Dactinomycin
  • Dexamethasone

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Carolyn F. Levy specialize in?
Is Carolyn F. Levy currently recruiting for clinical trials?
Are there any treatments that Carolyn F. Levy has studied deeply?
What is the best way to schedule an appointment with Carolyn F. Levy?
What is the office address of Carolyn F. Levy?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security